Last additions - Macular Degeneration - Age Related, Myopic, Choroidal Neovascular Membranes
|
Myopic CNVM Left Eye137 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye147 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye165 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye170 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye160 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye185 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Myopic CNVM Left Eye196 views80 year old female. VA dropped to 20/125 but improved back up to 20/50 with VabysmoNov 06, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion143 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion145 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion111 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion125 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion115 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion137 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion141 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion133 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion131 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion115 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion138 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion143 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion133 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion127 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion135 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion151 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion118 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion145 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion126 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion111 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion112 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion138 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion107 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
Wet AMD - Type 1 CNVM - RAP lesion126 views92 year old man with vision loss and very high PED. Because of worry about a PED tear, patient was treated with avastin, then lucentis, then eyelea, then vabysmo (progressively stronger meds)Sep 16, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye217 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye144 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye111 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye114 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye117 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye161 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye118 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye153 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye158 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye149 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye131 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye116 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye130 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye150 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye167 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye153 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye105 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye100 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye146 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye117 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye134 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye153 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye153 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye142 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye171 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye144 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye159 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
wet AMD with classic extrafoveal macular neovascularization in the good eye145 views89 year old man with longstanding vision loss in the left eye presented with one month of mild vision loss in the right eye. Vision was 20/32. This eye responded to vabysmo therapy.Apr 21, 2024
|
|
Large Hyper-reflective drusen in age-related macular degeneration252 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration255 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration226 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration211 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration246 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration238 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration247 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration238 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Large Hyper-reflective drusen in age-related macular degeneration250 views69 year old healthy woman with 20/20 vision and no visual complaintsSep 22, 2023
|
|
Non exudative MNV204 viewsSep 18, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion237 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion223 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion223 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion207 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion212 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion250 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion233 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion233 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Dry Macular Degeneration with Pseudodrusen and vitelliform lesion269 views80 year old female with 20/50 vision in both eyes. Mild blurringSep 17, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years223 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years247 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years211 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years218 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years208 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years246 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years223 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years209 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years221 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years193 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years204 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years201 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years216 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years209 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years198 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years185 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years229 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years247 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years213 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years244 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years230 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
Myopic (maybe PIC) choroidal neovascular membrane with recurrence after 6 years252 views31 year old female presented with 20/100 vision OS in 2017. Was treated with Lucentis x 6 and improved to 20/32. Then she was lost to follow-up. She represented 6 years later with 20/50 vision OS and a large recurrence and restarted treatment.Sep 16, 2023
|
|
| 2694 files on 27 page(s) |
 |
3 | |
|
|
|
|
|
|
|
|
